The role of interleukin-I beta in Helicobacter pylori-associated disease

E M El-Omar

Research output: Contribution to journalArticle

Abstract

Helicobacter pylori infects half the world's population and is associated with serious human diseases including peptic ulcer disease and gastric neoplasia. The clinical outcome is largely dependent on the severity and distribution of the H. pylori-induced gastritis. The reasons for such variable clinical outcomes remain poorly understood. Bacterial virulence factors contribute to the pathogenicity but do not explain the divergent outcomes. There is emerging evidence that host genetic factors play a key role in determining the clinical outcome to H. pylori infection. In particular, proinflammatory genotypes of the interleukin-1 beta (IL-1beta) gene are associated with increased risk of gastric cancer and its precursors. The effects are most likely mediated through induction of hypochlorhydria and severe corpus gastritis with subsequent development of gastric atrophy. In this article we discuss the role of IL-1beta and other host genetic factors in the pathogenesis of H. pylori-related disease.

Original languageEnglish
Pages (from-to)47-52
Number of pages6
JournalNetherlands Journal of Medicine
Volume62
Publication statusPublished - 2004

Keywords

  • ANTAGONIST GENE POLYMORPHISM
  • ACID SUPPRESSIVE THERAPY
  • DUODENAL-ULCER DISEASE
  • RECEPTOR ANTAGONIST
  • RHEUMATOID-ARTHRITIS
  • ATROPHIC GASTRITIS
  • ALOPECIA-AREATA
  • CANCER
  • STOMACH
  • RISK

Cite this

The role of interleukin-I beta in Helicobacter pylori-associated disease. / El-Omar, E M .

In: Netherlands Journal of Medicine, Vol. 62, 2004, p. 47-52.

Research output: Contribution to journalArticle

@article{116f3dbcc789419e9a0e4246cb192a1f,
title = "The role of interleukin-I beta in Helicobacter pylori-associated disease",
abstract = "Helicobacter pylori infects half the world's population and is associated with serious human diseases including peptic ulcer disease and gastric neoplasia. The clinical outcome is largely dependent on the severity and distribution of the H. pylori-induced gastritis. The reasons for such variable clinical outcomes remain poorly understood. Bacterial virulence factors contribute to the pathogenicity but do not explain the divergent outcomes. There is emerging evidence that host genetic factors play a key role in determining the clinical outcome to H. pylori infection. In particular, proinflammatory genotypes of the interleukin-1 beta (IL-1beta) gene are associated with increased risk of gastric cancer and its precursors. The effects are most likely mediated through induction of hypochlorhydria and severe corpus gastritis with subsequent development of gastric atrophy. In this article we discuss the role of IL-1beta and other host genetic factors in the pathogenesis of H. pylori-related disease.",
keywords = "ANTAGONIST GENE POLYMORPHISM, ACID SUPPRESSIVE THERAPY, DUODENAL-ULCER DISEASE, RECEPTOR ANTAGONIST, RHEUMATOID-ARTHRITIS, ATROPHIC GASTRITIS, ALOPECIA-AREATA, CANCER, STOMACH, RISK",
author = "El-Omar, {E M}",
year = "2004",
language = "English",
volume = "62",
pages = "47--52",
journal = "Netherlands Journal of Medicine",
issn = "0300-2977",
publisher = "Van Zuiden Communications BV",

}

TY - JOUR

T1 - The role of interleukin-I beta in Helicobacter pylori-associated disease

AU - El-Omar, E M

PY - 2004

Y1 - 2004

N2 - Helicobacter pylori infects half the world's population and is associated with serious human diseases including peptic ulcer disease and gastric neoplasia. The clinical outcome is largely dependent on the severity and distribution of the H. pylori-induced gastritis. The reasons for such variable clinical outcomes remain poorly understood. Bacterial virulence factors contribute to the pathogenicity but do not explain the divergent outcomes. There is emerging evidence that host genetic factors play a key role in determining the clinical outcome to H. pylori infection. In particular, proinflammatory genotypes of the interleukin-1 beta (IL-1beta) gene are associated with increased risk of gastric cancer and its precursors. The effects are most likely mediated through induction of hypochlorhydria and severe corpus gastritis with subsequent development of gastric atrophy. In this article we discuss the role of IL-1beta and other host genetic factors in the pathogenesis of H. pylori-related disease.

AB - Helicobacter pylori infects half the world's population and is associated with serious human diseases including peptic ulcer disease and gastric neoplasia. The clinical outcome is largely dependent on the severity and distribution of the H. pylori-induced gastritis. The reasons for such variable clinical outcomes remain poorly understood. Bacterial virulence factors contribute to the pathogenicity but do not explain the divergent outcomes. There is emerging evidence that host genetic factors play a key role in determining the clinical outcome to H. pylori infection. In particular, proinflammatory genotypes of the interleukin-1 beta (IL-1beta) gene are associated with increased risk of gastric cancer and its precursors. The effects are most likely mediated through induction of hypochlorhydria and severe corpus gastritis with subsequent development of gastric atrophy. In this article we discuss the role of IL-1beta and other host genetic factors in the pathogenesis of H. pylori-related disease.

KW - ANTAGONIST GENE POLYMORPHISM

KW - ACID SUPPRESSIVE THERAPY

KW - DUODENAL-ULCER DISEASE

KW - RECEPTOR ANTAGONIST

KW - RHEUMATOID-ARTHRITIS

KW - ATROPHIC GASTRITIS

KW - ALOPECIA-AREATA

KW - CANCER

KW - STOMACH

KW - RISK

M3 - Article

VL - 62

SP - 47

EP - 52

JO - Netherlands Journal of Medicine

JF - Netherlands Journal of Medicine

SN - 0300-2977

ER -